The causative pathogens of onychomycosis in southern Taiwan

Mycoses

Volumn 48, Issue 6, 2005, Pages 413-420

  Chi, Ching Chi ^a,b,c   Wang, Shu Hui ^a   Chou, Ming Chih ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Odds ratio; Onychomycosis; Pathogen; Southern Taiwan

Indexed keywords

ANTIFUNGAL AGENT;

ADULT; AGED; ARTICLE; CANDIDA; DERMATOPHYTE; DIABETES MELLITUS; DRUG CHOICE; FEMALE; FINGERNAIL ONYCHOMYCOSIS; FUNGUS CULTURE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOULD; NONHUMAN; OCCUPATION; ONYCHOMYCOSIS; PARONYCHIA; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; TOENAIL ONYCHOMYCOSIS; TROPICS; ARTHRODERMA; CANDIDIASIS; CLASSIFICATION; DRUG EFFECT; FUNGUS; HAND DISEASE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RISK; SEX DIFFERENCE; SKIN DISEASE;

ARTHRODERMATACEAE; CANDIDA; FUNGI;

ADULT; ARTHRODERMATACEAE; CANDIDA; CANDIDIASIS; DIABETES COMPLICATIONS; FEMALE; FOOT DERMATOSES; FUNGI; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; ONYCHOMYCOSIS; PARONYCHIA; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 33644668777     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2005.01152.x     Document Type: Article

References (18)

1. Gupta AK, Ryder JE. How to improve cure rates for the management of onychomycosis. Dermatol Clin 2003 21 : 491 505.
2. Arrese JE, Piérard GE. Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology 2003 207 : 251 60.
3. Elewski BE, Charif MA, Daniel CR III. Onychomycosis. In: Scher RK, Daniel CR III. (eds Nails: Therapy, Diagnosis, Surgery, 2nd edn. Philadelphia, USA : W.B. Saunders, 1997 : 151 62.
4. Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti A. Baran and Dawber's Diseases of the Nails and their Management, 3rd edn. London, UK : Blackwell Science, 2001.
5. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol 1998 139 : 561 71.
6. Daniel CR III., Gupta AK, Daniel MP, Sullivan S. Candida infection of the nail: role of Candida as a primary or secondary pathogen. Int J Dermatol 1998 37 : 901 7.
7. Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000 43 : 241 8.
8. Bokhari MA, Hussain I, Jahangir M, Haroon TS, Aman S, Khurshid K. Onychomycosis in Lahore, Pakistan. Int J Dermatol 1999 38 : 591 5.
9. Zaias N. Onychomycosis. Arch Dermatol 1972 105 : 261 74.
10. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000 42 : 211 24.
11. Gianni C, Cerri A, Crosti C. Non-dermatophytic onychomycosis. An underestimated entity? A study of 51 cases. Mycoses 2000 43 : 21 33.
12. Gupta AK, Konnikov N, MacDonald P et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998 139 : 661 71.
13. Dogra S, Kumar B, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002 41 : 641 51.
14. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses 1989 32 : 601 19.
15. Clayton YM. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses. Clin Exp Dermatol 1992 17 (Suppl. 1 31 40.
16. Rigopoulos D, Katsiboulas V, Koumantaki E, Emmanouil P, Papanicolaou A, Katsambas A. Epidemiology of onychomycosis in southern Greece. Int J Dermatol 1998 37 : 921 8.
17. Khosravi AR, Mansouri P. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole. Mycopathologia 2001 150 : 1 13.
18. Ellabib MS, Agaj M, Khalifa Z, Kavanagh K. Yeasts of the genus Candida are the dominant cause of onychomycosis in Libyan women but not men: results of a 2-year surveillance study. Br J Dermatol 2002 146 : 1031 41.